|
Durability is the best word to describe these dividend stocks.
|
RELATED ARTICLES | | | | |
|
Odds are good this is where the resorts start their recovery.
|
RELATED ARTICLES | | | | |
|
Walmart is getting new stock for PS5 pre-orders, so you'll get another chance to buy one soon. There's a catch, however.
|
|
 "Big Pharma" doesn't come much bigger than Pfizer (PFE). Although you could argue it is so big, the stock can hardly move. Shares are essentially trading for the same price as 3 years ago. Pfizer is also one of the leading names in the hunt for a COVID-19 vaccine. But unlike other names in the race to be first to market with a solution, the catalyst has had no bearing on the stock.However, after attending the company's investor presentation, Mizuho analyst Vamil Divan believes the event "successfully illustrated how the company is evolving into a ‘New Pfizer.'"Pfizer has an extensive pipeline of vaccines and treatments that it expects will generate over $15 billion of annual sales by 2025. The "New Pfizer" is also an attempt to highlight the giant's growth potential. The upcoming spin-off of its Upjohn portfolio should rid it of unwanted bulk and help it become an "innovation-driven biopharma company." The company expects to grow the top-line by 6% a year, while delivering double-digit growth on the bottom line.On the rare diseases front, Pfizer anticipates six rare disease assets will be in Phase 3 trials by the end of the year, including three gene therapies.The company is also developing a wide range of immunology products, "each for a targeted number of indications where there appears the potential for a truly differentiated product."Leading the charge form this business unit is abrocitinib, an oral JAK-inhibitor which Pfizer last month filed for the treatment of atopic dermatitis. Pfizer believes the treatmen
|
|
Friday was expected to be an active day for stocks, and, on that front, it didn't disappoint.
Today was a "quadruple witching" day, in which index futures, index options, stock options and individual-stock futures all expire at once, which sometimes leads to heavy volume and erratic moves in parts or all of the market. In this case, the major indices flipped from early gains to deep losses, then recovered somewhat before closing in the red. The Dow Jones Industrial Average finished 0.9% lower to 27,657.
SEE MORE 20 Best Stocks to Buy for the New Bull Market
Friday continued a brutal stretch for tech. The S&P 500's technology sector, as measured by the Technology Select Sector SPDR Fund (XLK, -1.7%), has declined 9.5% since the start of September. Apple (AAPL, -3.2%) has declined 17% this month, Amazon.com (AMZN, -1.8%) is off 14.4% and Microsoft (MSFT, -1.2%) is off 9.8%.
Other action in the stock market today:
The Nasdaq Composite dropped 1.1% to 10,793, putting it down 8.3% for September.The S&P 500 also fell 1.1% to 3,319.
The Russell 2000 was the strongest of the major indices, slipping 0.4% to 1,536.
Too Rocky for Your Tastes? Build a More Diversified
|
|
Private Label